Phytochemical Profiling, In-Vitro COX-2 Inhibition and In-Silico Evaluation of the Ethanolic Flower Extract of Rosa indica L.
Abstract
Background: Pain and inflammation are leading reasons for medical care, and the adverse effects of long-term NSAID and opioid use sustain interest in safer plant-derived alternatives. Rosa indica L. (Rosaceae) is traditionally used for wounds, headaches, and inflammatory complaints, but its anti-inflammatory mechanism remains poorly defined. Objective: To chemically characterise the ethanolic flower extract of Rosa indica and evaluate its COX-2 inhibitory potential using integrated in vitro and in silico approaches. Methods: Fresh authenticated flowers were cold-macerated in 95 % ethanol and concentrated below 40°C. The extract underwent qualitative phytochemical screening, GC–MS profiling and a concentration-dependent COX-2 inhibition assay with indomethacin as a standard. Major constituents were docked against COX-2 (PDB: 5IKR), assessed for drug-likeness, and the resulting complexes were subjected to RMSF analysis using CABS-flex 3.0. Results: Screening confirmed phenolics, flavonoids, alkaloids, tannins, saponins, steroids and glycosides. GC–MS identified 27 constituents, including pyrogallol, 2,4-di-tert-butylphenol, 5-hydroxymethylfurfural, DDMP, phenylethyl alcohol, vanillin lactoside, linoleic acid, and chondroitin sulfate. Ethanolic extract of Rosa indica inhibited COX-2 with an IC₅₀ of 624.5 ± 23.33 µg/mL, compared with 93.35 ± 0.88 % inhibition by indomethacin. Docking energies ranged from −7.0 to −8.7 kcal/mol, led by vanillin lactoside (−8.7) and chondrillasterol (−8.3). Phenylethyl alcohol and 2,4-di-tert-butylphenol showed was most drug-like lead strongest binders were least drug-like. RMSF values remained largely below 1.5 Å. Conclusion: The ethanolic flower extract of Rosa indica is a weak to moderate, multi-component COX-2 inhibitor whose activity most likely reflects additive contributions of phenolic, glycosidic, fatty acid, as well as steroidal constituents. These findings provide a mechanistic rationale for the traditional anti-inflammatory use of the plant and justify bioassay-guided fractionation and in-vivo validation, but do not by themselves establish therapeutic efficacy.